human midkine standard elisa development kit, page-2

I'm not sure this product is ours Hawkeye, but the CDY version could soon be onsold by US based resellers such as this ..... and without the "research uses only" caviet.

The Cellmid product is, as we know, the gold standard for MK Elisas.

When the news does eventually hit, it will hopefully include some sales projections so the market knows what it is responding to. My hope is that initial Evolis sales results are reported first to reinforce a new SP anchor point.

To be half serious, market cap should at least be in the $30 to $40m range with several revenue streams expected to grow significantly over the next 12 months.

The best part of your share register review is that there isn't much beyond a few larger holders taking up the placements and the few trades you reported. register non movement (to me) suggests a positive sentiment as holder wait for anticipated news.

Cheers